文献速递传染病防控与疫情报告

体外膜氧合(ECMO)用温度调节装置中检出奇美拉分枝杆菌的临床意义,德国,2015至2016年

Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016.
PubMed 文献 · Euro Surveill · 2016-01-01

该研究在德国一家呼吸科重症监护室开展前瞻性微生物学调查和回顾性临床回顾,发现18份ECMO温度调节装置水样中9份检出奇美拉分枝杆菌,9份房间空气及环境样本未检出;118例ECMO患者中76例送检支气管标本,3例检出该菌但采样时无感染征象。作者认为该菌可能对患者构成感染风险,需进一步研究其临床意义。

要点

  • 18份ECMO温度调节装置水样中9份检出奇美拉分枝杆菌
  • 9份房间空气及其他环境样本均未检出分枝杆菌
  • 76例送检支气管标本的ECMO患者中3例检出该菌,采样时无感染征象

核心结论

  • ECMO相关温度调节装置水样中可检出奇美拉分枝杆菌,可能对患者构成感染风险。
  • 需进一步研究以阐明该菌在ECMO治疗环境中的临床意义。

研究设计与样本

  • 前瞻性微生物学研究,检测ECMO系统水样及环境样本中的奇美拉分枝杆菌。
  • 回顾性临床回顾,在呼吸科重症监护室患者中排查可能的ECMO相关分枝杆菌感染。
  • 水样来自10台不同的ECMO温度调节装置,共18份;环境样本包括9份房间空气样本及其他环境样本。
  • 临床回顾纳入118例ECMO患者,其中76例分析了支气管标本。

主要发现

  • 18份来自10台ECMO温度调节装置的水样中9份检出奇美拉分枝杆菌。
  • 9份房间空气样本及其他环境样本均未检出分枝杆菌。
  • 118例ECMO患者中76例送检支气管标本,其中3例检出奇美拉分枝杆菌,采样时无分枝杆菌感染征象。

局限性

  • 需进一步研究以阐明奇美拉分枝杆菌在ECMO治疗环境中的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mycobacterium chimaera, a non-tuberculous mycobacterium, was recently identified as causative agent of deep-seated infections in patients who had previously undergone open-chest cardiac surgery. Outbreak investigations suggested an aerosol-borne pathogen transmission originating from water contained in heater-cooler units (HCUs) used during cardiac surgery. Similar thermoregulatory devices are used for extracorporeal membrane oxygenation (ECMO) and M. chimaera might also be detectable in ECMO treatment settings. We performed a prospective microbiological study investigating the occurrence of M. chimaera in water from ECMO systems and in environmental samples, and a retrospective clinical review of possible ECMO-related mycobacterial infections among patients in a pneumological intensive care unit. We detected M. chimaera in 9 of 18 water samples from 10 different thermoregulatory ECMO devices; no mycobacteria were found in the nine room air samples and other environmental samples. Among 118 ECMO patients, 76 had bronchial specimens analysed for mycobacteria and M. chimaera was found in three individuals without signs of mycobacterial infection at the time of sampling. We conclude that M. chimaera can be detected in water samples from ECMO-associated thermoregulatory devices and might potentially pose patients at risk of infection. Further research is warranted to elucidate the clinical significance of M. chimaera in ECMO treatment settings.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Trudzinski FC, Schlotthauer U, Kamp A, et al. Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016. Euro Surveill. 2016. PMID: 27918254. doi:10.2807/1560-7917.ES.2016.21.46.30398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。